LSC 2013 abstract - MicroRNA based biomarkers for early risk assessment of asthma Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013
Novel proteomic biomarkers in the evaluation of childhood asthma Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013
A new observer independent method to assess therapy response in children with severe asthma based on daily lung function Source: Annual Congress 2013 –Uncontrolled and severe asthma in children Year: 2013
Predicting later asthma in toddlers: Do environmental exposure data improve a clinical tool? Source: Annual Congress 2013 –Asthma, allergy and lung function: natural history and risk factors in longitudinal studies Year: 2013
ADEPT, airway disease endotyping for personalized treatment: Interim analysis of asthma patients Source: Annual Congress 2013 –Novel drugs and biomarkers in respiratory medicine Year: 2013
Exercise-induced bronchoconstriction in a school-age cohort: Prevalence, risk factors and utility of the Cooper test for its routine detection Source: International Congress 2014 – Alterations of exercise and lung function in different diseases Year: 2014
Allergen specific immunotherapy: Effect on immunological markers and clinical outcomes in asthmatic children Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma Year: 2016
Monitoring asthma in children: clinical tools Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force Year: 2014
Comparing non-invasive cardiovascular risk assessment tools in COPD patients: Validation with CV events Source: International Congress 2014 – Respiratory disease within hospital-based populations Year: 2014
Biomarker development in asthma from a patient's perspective Source: Breathe, 15 (4) 277; 10.1183/20734735.0303-2019 Year: 2019
The effect of different symptom and risk assessments in classifying pulmonary rehabilitation patients according to the new GOLD guidelines Source: International Congress 2014 – Non inflammatory monitoring of airway diseases Year: 2014
Integrating Comprehensive Geriatric Assessment for people with COPD and frailty starting pulmonary rehabilitation: the Breathe Plus feasibility trial protocol Source: ERJ Open Res, 7 (1) 00717-2020; 10.1183/23120541.00717-2020 Year: 2021
Mortality risk prediction in COPD by a prognostic biomarker panel – Results of a derivation and validation cohort with a long term follow-up Source: International Congress 2014 – Markers Year: 2014
Assessing asthma risk in primary care: Can the AAA test predict future asthma attacks? Source: International Congress 2014 – Biomarkers of asthma control Year: 2014
Identifying patients at risk for future exacerbations of asthma: Development of a prediction model Source: International Congress 2015 – Non-inflammatory monitoring of airway diseases Year: 2015
Late Breaking Abstract - Validation of a tool for the assessment of disease awareness (DA) in COPD Source: International Congress 2017 – COPD: from screening to risk factors of lung cancer Year: 2017
Cotinine level is associated with asthma severity in passive smoker children Source: International Congress 2015 – Molecular pathways of lung injury due to tobacco-related products Year: 2015
Is early diagnosis of COPD possible? Preliminary results of early COPD study Source: International Congress 2014 – Monitoring airway diseases with lung function tests Year: 2014
COPD related fatigue (COPD-RF) as a patient centred outcome tool in COPD: Various predictors and its correlation with other outcome parameters Source: International Congress 2016 – Monitoring airway diseases with clinical tools Year: 2016
Validation of self-reported asthma in a generation study Source: International Congress 2016 – Asthma and allergy in infancy: from risk factors to mortality Year: 2016